Summary
Background
We previously found a higher incidence of circulating tumour cells (CTCs) in women with metastatic breast cancer compared to early disease. In this study, we present follow-up data to explore the prognostic significance of these findings.
Methods
CTCs were quantified by immunostaining and direct visualization after centrifugation and filtration enrichment of peripheral blood from 131 patients. Time to progression (TTP) and overall survival (OS) were defined as interval from first blood sampling to first documented disease progression, or death respectively. Lifetime data was analysed using Kaplan–Meier method, log-rank test and Cox proportional hazards model.
Results
Follow-up data is available for 123 patients. In early disease, median CTC≥4 best distinguished patients with shorter TTP (p=0.05, log-rank test). In univariate analysis, tumour size, grade, lymphovascular invasion (LVI) and receptor status significantly related to TTP but none of the covariates related to OS. In multivariate analysis, T stage was the only independent predictor of TTP. In metastatic disease, median CTC≥13 optimally identified patients with shorter TTP (p=0.01). In univariate analysis, median CTC level ≥13 and prior lines of chemotherapy predicted for TTP while in multivariate analysis, median CTC level ≥13 was the only significant independent prognostic factor (p=0.02). No relationship between CTC level and OS was found in this subgroup.
Conclusion
Median CTC level determined in the course of treatment predicts for TTP in metastatic breast cancer. In early breast cancer, an association was found between CTC level and TTP although this did not reach statistical significance (p=0.05).
Similar content being viewed by others
References
Asworth TR, A case of cancer in which cells similar to those in tumors were seen in the blood after death Aust Med J 14: 146, 1869
Chritopherson WM, Cancer cells in the peripheral blood: a second look Acta Cytol 86:169–174, 1965
Redding WH, Coombes RC, Monaghan P, Clink HM, Imrie SF, Dearnaley DP, Ormerod MG, Sloane JP, Gazet JC, Powles TJ, Detection of micrometastases in patients with primary breast cancer Lancet 2: 1271–1274, 1983
Stahel RA, Mabry M, Skarin AT, Speak J, Bernal SD, Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody J Clin Oncol 3: 455–461, 1985
Moss TJ, Sanders DG, Detection of neuroblastoma cells in blood J Clin Oncol 8: 736–740, 1990
Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA, Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification Science 237:175–178, 1987
Cave H, Guidal C, Rohrlich P, Delfau MH, Broyart A, Lescoeur B, Rahimy C, Fenneteau O, Monplaisir N, d’Auriol L, Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes Blood 83:1892–1902, 1994
Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M, Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction J Clin Oncol 12: 725–729, 1994
Campana D, Pui CH, Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance Blood 85:1416–1434, 1995
Miyajima Y, Kato K, Numata S, Kudo K, Horibe K, Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA Cancer 75: 2757–2761, 1995
Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K, Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood Cancer 75: 2214–2219, 1995
Ring A, Smith IE, Dowsett M, Circulating tumour cells in breast cancer Lancet Oncol 5:79–88, 2004
Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis Ch, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D, Georgoulias V, Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance J Clin Oncol 20: 3404–3412, 2002
Smith BM, Slade MJ, English J, Graham H, Luchtenborg M, Sinnett HD, Cross NC, Coombes RC, Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques J Clin Oncol 18:1432–1439, 2000
Weigelt B, Bosma AJ, Hart AA, Rodenhuis S, van ‘t Veer LJ, Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients Br J Cancer 88:1091–1094, 2003
Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW, Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases Clin Cancer Res 10:6897–6904, 2004
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF, Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351:781–791, 2004
Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW, Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer J Clin Oncol 23:1420–1430, 2005
Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, Holloway C, McCready DR, Maclean D, Marks A, Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage Breast Cancer Res Treat 86: 237–247, 2004
Kahn HJ, Yang LY, Blondal J, Lickley L, Holloway C, Hanna W, Narod S, McCready DR, Seth A, Marks A, RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters Breast Cancer Res Treat 60: 143–151, 2000
Terstappen LW, Rao C, Gross S, Weiss AJ, Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast Int J Oncol 17: 573–578, 2000
Pachmann K, Clement JH, Hoeffken K, Schneider C, Lobodasch K, Camara O, Pachmann U: Quantitative monitoring of circulating epithelial cells for individual therapy control in lung and breast cancer during neoadjuvant treatment, surgery and adjuvant chemotherapy [abstract]. Am Soc Clin Oncol Abstract 631, 2005
Almokadem S, Leitzel K, Harvey HA, Bannon E, Ali SM, Miller C, Repollet M, Allard WJ, Terstappen L, Lipton A: Circulating tumor cells in adjuvant breast cancer patients [abstract]. Am Soc Clin Oncol Abstract 667, 2005
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wong, N., Kahn, H., Zhang, L. et al. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Breast Cancer Res Treat 99, 63–69 (2006). https://doi.org/10.1007/s10549-006-9181-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-006-9181-4